Intellectual Property India Publishes Patent Application for 'Pyridazinyl Amino Derivatives As Alk5 Inhibitors' Filed by Chiesi Farmaceutici S. P. A.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517090313 A) filed by Chiesi Farmaceutici S. P. A., Parma, Italy, on Sept. 22, for 'pyridazinyl amino derivatives as alk5 inhibitors.'

Inventor(s) include Pizzirani, Daniela; Ronchi, Paolo; Pala, Daniele; and Rescigno, Donatella.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present invention generally relates to compounds (I) inhibiting the transforming growth factor (TGF ) type I receptor (ALK5) (hereinafter ALK5 inhibitors), methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful for instance in the treatment of many diseases, disorders, or conditions associated with ALK5 signaling pathway."

The patent application was internationally filed on Mar. 01, 2024, under International application No.PCT/EP2024/055317.

Disclaimer: Curated by HT Syndication.